← Back to Search

Behavioral Intervention

CBT-txt for Depression

Waitlist Available
Led By Michael J Mason, PhD
Research Sponsored by The University of Tennessee, Knoxville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 2 month, 3 month
Awards & highlights

Study Summary

This trial will test whether CBT-txt can reduce depressive symptoms when delivered via text message.

Eligible Conditions
  • Depression


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 2 month, 3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 2 month, 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Depression
Mental Depression
Secondary outcome measures
Mental Depression
Change from Baseline Behavioral Activation for Depression Scale at 3 Months
Change from Baseline Perseverative Thinking Questionnaire at 2 Months
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
This arm will receive 8 weeks of the text-based intervention (CBT-txt). CBT-txt is a version of Cognitive Behavioral Therapy tailored to be delivered by automated text message. This arm will also complete surveys at baseline, 1 month, 2 months, and 3 months.
Group II: Waitlist ControlActive Control1 Intervention
This arm will not receive the text-based intervention during study participation. These participants will only complete surveys at baseline, 1 month, 2 months, and 3 months and will be given the option to receive CBT-txt after they complete study participation.

Find a Location

Who is running the clinical trial?

The University of Tennessee, KnoxvilleLead Sponsor
83 Previous Clinical Trials
18,456 Total Patients Enrolled
Michael J Mason, PhDPrincipal InvestigatorUniversity of Tennessee-Knoxville

Media Library

CBT-txt (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05551702 — N/A
Depression Research Study Groups: Treatment, Waitlist Control
Depression Clinical Trial 2023: CBT-txt Highlights & Side Effects. Trial Name: NCT05551702 — N/A
CBT-txt (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05551702 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any specific criteria for participants to qualify for this research trial?

"This medical study, which is looking for 103 participants, seeks volunteers who are between 18 to 25 years of age and have been diagnosed with depression."

Answered by AI

Is the age range for participation in this trial inclusive of individuals under 50?

"This study is exclusively for those aged between 18 and 25. There are 211 clinical studies available to people younger than 18, with 1003 trials open to patients older than 65 years of age."

Answered by AI

Are there available spots for participants in this trial?

"As per the information hosted on clinicaltrials.gov, this particular medical trial is not currently taking in new participants. The study was initially posted on July 6th 2022 and last updated on May 8th 2023. Despite its status as inactive, there are presently 1356 other trials actively recruiting candidates."

Answered by AI

What are the desired effects of this clinical experiment?

"This study's primary outcome, which will be evaluated at Baseline, 1 Month, 2 Months and 3 Months is the Change from Baseline Beck Depression Inventory II score at 3 months. Other secondary appraisals include a 10-item Types of Thinking Cognitive Distortion Scale to recognize cognitive distortions (minimum 20 points; maximum 140 points with higher scores signifying more cognitive distortion), as well as two 15-item Perseverative Thinking Questionnaires that measure repetitive negative thinking (minimum 0 points; maximum 60 with higher numbers meaning greater perseverative thought)."

Answered by AI
~37 spots leftby Apr 2025